Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of PanChol, a Novel Live Attenuated Oral Cholera Vaccine, in Zambia Adults

NCT07107516 is registered in ClinicalTrials.gov with Centre for Infectious Disease Research in Zambia as lead sponsor.

NCT NCT07107516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of PanChol, a Novel Live Attenuated Oral Cholera Vaccine, in Zambia Adults
Lead sponsor
Centre for Infectious Disease Research in Zambia
Phase
Phase 1
Overall status
Recruiting
Start date
May 20, 2026
Completion date
January 31, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholera vaccination reaction